Annual Working Capital
$48.09 M
+$40.99 M+576.97%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual working capital is $48.09 million, with the most recent change of +$40.99 million (+576.97%) on December 31, 2023.
- During the last 3 years, SABS annual working capital has risen by +$24.70 million (+105.59%).
- SABS annual working capital is now at all-time high.
Performance
SABS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$23.72 M
-$8.31 M-25.94%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly working capital is $23.72 million, with the most recent change of -$8.31 million (-25.94%) on September 30, 2024.
- Over the past year, SABS quarterly working capital has increased by +$29.80 million (+489.94%).
- SABS quarterly working capital is now -50.68% below its all-time high of $48.09 million, reached on December 31, 2023.
Performance
SABS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SABS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +577.0% | +489.9% |
| 3 y3 years | +105.6% | +366.9% |
| 5 y5 years | +929.7% | +366.9% |
SABS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +577.0% | -50.7% | +489.9% |
| 5 y | 5-year | at high | +929.7% | -50.7% | +489.9% |
| alltime | all time | at high | +929.7% | -50.7% | +489.9% |
SAB Biotherapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.72 M(-25.9%) |
| Jun 2024 | - | $32.03 M(-17.1%) |
| Mar 2024 | - | $38.65 M(-19.6%) |
| Dec 2023 | $48.09 M(+577.0%) | $48.09 M(-890.6%) |
| Sep 2023 | - | -$6.08 M(+203.4%) |
| Jun 2023 | - | -$2.00 M(-246.7%) |
| Mar 2023 | - | $1.37 M(-80.8%) |
| Dec 2022 | $7.10 M | $7.10 M(+39.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.08 M(-56.3%) |
| Jun 2022 | - | $11.61 M(-35.2%) |
| Mar 2022 | - | $17.91 M(-24.5%) |
| Dec 2021 | $23.74 M(+1.5%) | $23.74 M(+5196.0%) |
| Sep 2021 | - | $448.20 K(-97.4%) |
| Jun 2021 | - | $17.57 M(-24.9%) |
| Dec 2020 | $23.39 M(+400.9%) | $23.39 M |
| Dec 2019 | $4.67 M | - |
FAQ
- What is SAB Biotherapeutics annual working capital?
- What is the all time high annual working capital for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual working capital year-on-year change?
- What is SAB Biotherapeutics quarterly working capital?
- What is the all time high quarterly working capital for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly working capital year-on-year change?
What is SAB Biotherapeutics annual working capital?
The current annual working capital of SABS is $48.09 M
What is the all time high annual working capital for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual working capital is $48.09 M
What is SAB Biotherapeutics annual working capital year-on-year change?
Over the past year, SABS annual working capital has changed by +$40.99 M (+576.97%)
What is SAB Biotherapeutics quarterly working capital?
The current quarterly working capital of SABS is $23.72 M
What is the all time high quarterly working capital for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly working capital is $48.09 M
What is SAB Biotherapeutics quarterly working capital year-on-year change?
Over the past year, SABS quarterly working capital has changed by +$29.80 M (+489.94%)